Cancer Immunotherapy Is More Than a Numbers Game

See allHide authors and affiliations

Science  06 Oct 2006:
Vol. 314, Issue 5796, pp. 68-69
DOI: 10.1126/science.1133893

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution


White blood cells that are genetically engineered to destroy human melanoma prove effective for a few patients in a clinical trial. A variety of strategies might increase the success rate.